Advertisements & Sales Promotion Control
The objectives of advertisement controls for health and medicinal products is to ensure that accurate and factual information about the products is disseminated and to ensure that the advertisements and sales promotion activities do not mislead consumers or induce unnecessary purchase or consumption of the products.
As part of HSA’s ongoing initiative to update and streamline the regulatory controls for health products, pharmaceutical products, commonly referred to as chemical and biologic drugs, has been introduced as “therapeutic products” (TP) under the Health Products Act (HPA) on 15 July 2016. The regulatory controls on TP is effective from 1 November 2016. Please click here for an overview of the port-over exercise and its implementation.
The advertisements and sales promotion of TP are controlled under the HPA and its subsidiary legislation, the Health Products (Advertisement of Therapeutic Products) Regulations. Advertisements and sales promotions of medicinal products remains under the control of the Medicines Act and its subsidiary legislation, the Medicines (Medical Advertisements) Regulations.